Suppr超能文献

抗微管药物处理后C6大鼠胶质瘤细胞中S100蛋白β亚基mRNA的减少

Reduction in S100 protein beta subunit mRNA in C6 rat glioma cells following treatment with anti-microtubular drugs.

作者信息

Dunn R, Landry C, O'Hanlon D, Dunn J, Allore R, Brown I, Marks A

出版信息

J Biol Chem. 1987 Mar 15;262(8):3562-6.

PMID:3818655
Abstract

S100 protein is a calcium-binding protein found in vertebrate nervous tissue. Synthesis of S100 protein in the rat glioma cell line, C6, is inhibited by the addition of anti-microtubular drugs. We have cloned a cDNA for the beta subunit of S100 protein from rat brain in a lambda gt 11 expression vector and used this cDNA to measure the amounts of S100 beta subunit mRNA in C6 cells after treatment with anti-microtubular drugs. Levels of alpha-tubulin and beta-actin mRNAs were also measured. All measurements were performed using RNA-RNA hybridization techniques at high stringency with rat mRNA-specific probes. After 24 h of treatment, the S100 beta subunit mRNA was reduced to levels of 25% by colchicine and 32% by vinblastine when compared to untreated controls. In contrast, the levels of tubulin and actin mRNAs were only slightly changed by these treatments. These studies demonstrate that disruption of the microtubular cytoskeleton causes a specific reduction in the level of S100 protein mRNA in C6 cells.

摘要

S100蛋白是一种在脊椎动物神经组织中发现的钙结合蛋白。在大鼠胶质瘤细胞系C6中,抗微管药物的添加会抑制S100蛋白的合成。我们已将大鼠脑中S100蛋白β亚基的cDNA克隆到λgt 11表达载体中,并使用该cDNA来测量抗微管药物处理后C6细胞中S100β亚基mRNA的量。同时也测量了α-微管蛋白和β-肌动蛋白mRNA的水平。所有测量均使用RNA-RNA杂交技术,采用与大鼠mRNA特异性探针的高严谨度杂交。处理24小时后,与未处理的对照相比,秋水仙碱使S100β亚基mRNA水平降至25%,长春碱使其降至32%。相反,这些处理对微管蛋白和肌动蛋白mRNA水平的影响很小。这些研究表明,微管细胞骨架的破坏会导致C6细胞中S100蛋白mRNA水平的特异性降低。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验